Effects of opioid be drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function

Tony L. Sahley, Robin B. Kalish, Frank Musiek, Douglas W. Hoffman

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Multiple gene products of opioid peptide families (e.g., enkephalins, dynorphins) with differing opioid receptor specificities are present within olivocochlear efferent terminals. Enkephalins activate μ- and δ-opioid receptors, and are generally inhibitory in the nervous system, and dynorphins are κ-receptor agonists, which may be excitatory to postsynaptic neurons. We have examined the effects of intravenously administered opioid agonists and antagonists on click-evoked N1 and N2 amplitudes and latencies of the compound action potential in the chinchilla recorded at the round window. Parenteral administration of the opioid receptor antagonist naloxone or the potent μ-receptor agonist fentanyl did not alter N1 and N2 amplitudes or latencies. The κ-receptor agonist, μ-receptor antagonist pentazocine caused marked increases in N1 and N2 amplitudes over baseline values at threshold intensities. These effects were not abolished by naloxone. No effects were seen on the cochlear microphonic, supporting a site of action of these effects at the lateral olivocochlear efferent terminals on auditory nerve dendrites under inner hair cells. Similar results were obtained when far field auditory evoked responses were recorded. Results were obtained under ketamine/pentobarbital anesthesia, which provided stable recording baselines in contrast to tiletamine/zolezepam/pentobarbital, with which an upward drift in auditory potentials was observed. This stimulatory action of κ-agonists on auditory-evoked potential amplitudes appears to represent a physiological role of the lateral olivocochlear efferent innervation. The different neurotransmitters of the olivocochlear efferents (e.g.enkephalins, dynorphins, acetylcholine) may have antagonistic actions on auditory potentials, as may the lateral and medial systems themselves.

Original languageEnglish (US)
Pages (from-to)133-142
Number of pages10
JournalHearing Research
Volume55
Issue number1
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Dynorphins
Auditory Evoked Potentials
Enkephalins
Opioid Analgesics
Narcotic Antagonists
Opioid Receptors
Pentobarbital
Naloxone
Inner Auditory Hair Cells
Tiletamine
Pharmaceutical Preparations
Chinchilla
Pentazocine
Cochlear Nerve
Opioid Peptides
Cochlea
Ketamine
Fentanyl
Dendrites
Nervous System

Keywords

  • Auditory evoked potential
  • Cochlea
  • Dynorphin
  • Olivocochlear efferent bundle
  • Opioid
  • Opioid peptides
  • Pentazocine
  • U50-488

ASJC Scopus subject areas

  • Sensory Systems

Cite this

Effects of opioid be drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function. / Sahley, Tony L.; Kalish, Robin B.; Musiek, Frank; Hoffman, Douglas W.

In: Hearing Research, Vol. 55, No. 1, 1991, p. 133-142.

Research output: Contribution to journalArticle

@article{7c22d53fbd8b41a6bafaff04a8bdb744,
title = "Effects of opioid be drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function",
abstract = "Multiple gene products of opioid peptide families (e.g., enkephalins, dynorphins) with differing opioid receptor specificities are present within olivocochlear efferent terminals. Enkephalins activate μ- and δ-opioid receptors, and are generally inhibitory in the nervous system, and dynorphins are κ-receptor agonists, which may be excitatory to postsynaptic neurons. We have examined the effects of intravenously administered opioid agonists and antagonists on click-evoked N1 and N2 amplitudes and latencies of the compound action potential in the chinchilla recorded at the round window. Parenteral administration of the opioid receptor antagonist naloxone or the potent μ-receptor agonist fentanyl did not alter N1 and N2 amplitudes or latencies. The κ-receptor agonist, μ-receptor antagonist pentazocine caused marked increases in N1 and N2 amplitudes over baseline values at threshold intensities. These effects were not abolished by naloxone. No effects were seen on the cochlear microphonic, supporting a site of action of these effects at the lateral olivocochlear efferent terminals on auditory nerve dendrites under inner hair cells. Similar results were obtained when far field auditory evoked responses were recorded. Results were obtained under ketamine/pentobarbital anesthesia, which provided stable recording baselines in contrast to tiletamine/zolezepam/pentobarbital, with which an upward drift in auditory potentials was observed. This stimulatory action of κ-agonists on auditory-evoked potential amplitudes appears to represent a physiological role of the lateral olivocochlear efferent innervation. The different neurotransmitters of the olivocochlear efferents (e.g.enkephalins, dynorphins, acetylcholine) may have antagonistic actions on auditory potentials, as may the lateral and medial systems themselves.",
keywords = "Auditory evoked potential, Cochlea, Dynorphin, Olivocochlear efferent bundle, Opioid, Opioid peptides, Pentazocine, U50-488",
author = "Sahley, {Tony L.} and Kalish, {Robin B.} and Frank Musiek and Hoffman, {Douglas W.}",
year = "1991",
doi = "10.1016/0378-5955(91)90099-U",
language = "English (US)",
volume = "55",
pages = "133--142",
journal = "Hearing Research",
issn = "0378-5955",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Effects of opioid be drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function

AU - Sahley, Tony L.

AU - Kalish, Robin B.

AU - Musiek, Frank

AU - Hoffman, Douglas W.

PY - 1991

Y1 - 1991

N2 - Multiple gene products of opioid peptide families (e.g., enkephalins, dynorphins) with differing opioid receptor specificities are present within olivocochlear efferent terminals. Enkephalins activate μ- and δ-opioid receptors, and are generally inhibitory in the nervous system, and dynorphins are κ-receptor agonists, which may be excitatory to postsynaptic neurons. We have examined the effects of intravenously administered opioid agonists and antagonists on click-evoked N1 and N2 amplitudes and latencies of the compound action potential in the chinchilla recorded at the round window. Parenteral administration of the opioid receptor antagonist naloxone or the potent μ-receptor agonist fentanyl did not alter N1 and N2 amplitudes or latencies. The κ-receptor agonist, μ-receptor antagonist pentazocine caused marked increases in N1 and N2 amplitudes over baseline values at threshold intensities. These effects were not abolished by naloxone. No effects were seen on the cochlear microphonic, supporting a site of action of these effects at the lateral olivocochlear efferent terminals on auditory nerve dendrites under inner hair cells. Similar results were obtained when far field auditory evoked responses were recorded. Results were obtained under ketamine/pentobarbital anesthesia, which provided stable recording baselines in contrast to tiletamine/zolezepam/pentobarbital, with which an upward drift in auditory potentials was observed. This stimulatory action of κ-agonists on auditory-evoked potential amplitudes appears to represent a physiological role of the lateral olivocochlear efferent innervation. The different neurotransmitters of the olivocochlear efferents (e.g.enkephalins, dynorphins, acetylcholine) may have antagonistic actions on auditory potentials, as may the lateral and medial systems themselves.

AB - Multiple gene products of opioid peptide families (e.g., enkephalins, dynorphins) with differing opioid receptor specificities are present within olivocochlear efferent terminals. Enkephalins activate μ- and δ-opioid receptors, and are generally inhibitory in the nervous system, and dynorphins are κ-receptor agonists, which may be excitatory to postsynaptic neurons. We have examined the effects of intravenously administered opioid agonists and antagonists on click-evoked N1 and N2 amplitudes and latencies of the compound action potential in the chinchilla recorded at the round window. Parenteral administration of the opioid receptor antagonist naloxone or the potent μ-receptor agonist fentanyl did not alter N1 and N2 amplitudes or latencies. The κ-receptor agonist, μ-receptor antagonist pentazocine caused marked increases in N1 and N2 amplitudes over baseline values at threshold intensities. These effects were not abolished by naloxone. No effects were seen on the cochlear microphonic, supporting a site of action of these effects at the lateral olivocochlear efferent terminals on auditory nerve dendrites under inner hair cells. Similar results were obtained when far field auditory evoked responses were recorded. Results were obtained under ketamine/pentobarbital anesthesia, which provided stable recording baselines in contrast to tiletamine/zolezepam/pentobarbital, with which an upward drift in auditory potentials was observed. This stimulatory action of κ-agonists on auditory-evoked potential amplitudes appears to represent a physiological role of the lateral olivocochlear efferent innervation. The different neurotransmitters of the olivocochlear efferents (e.g.enkephalins, dynorphins, acetylcholine) may have antagonistic actions on auditory potentials, as may the lateral and medial systems themselves.

KW - Auditory evoked potential

KW - Cochlea

KW - Dynorphin

KW - Olivocochlear efferent bundle

KW - Opioid

KW - Opioid peptides

KW - Pentazocine

KW - U50-488

UR - http://www.scopus.com/inward/record.url?scp=0025816382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025816382&partnerID=8YFLogxK

U2 - 10.1016/0378-5955(91)90099-U

DO - 10.1016/0378-5955(91)90099-U

M3 - Article

C2 - 1684359

AN - SCOPUS:0025816382

VL - 55

SP - 133

EP - 142

JO - Hearing Research

JF - Hearing Research

SN - 0378-5955

IS - 1

ER -